We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$25.3B
AUM Growth
+$814M
Cap. Flow
+$613M
Cap. Flow %
2.42%
Top 10 Hldgs %
16.08%
Holding
3,081
New
5
Increased
1,358
Reduced
932
Closed
769

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$31.9M
2
AAPL icon
Apple
AAPL
+$24.9M
3
T icon
AT&T
T
+$21.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$20.2M
5
BIIB icon
Biogen
BIIB
+$19.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$34M
2
RHT
Red Hat Inc
RHT
+$22.2M
3
HSBC icon
HSBC
HSBC
+$20.3M
4
APC
Anadarko Petroleum
APC
+$19.9M
5
CAJ
Canon, Inc.
CAJ
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Financials 16.76%
3 Healthcare 12.56%
4 Consumer Discretionary 10.05%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUTR
2801
DELISTED
Cutera, Inc.
CUTR
-631
Closed -$13K
BEST
2802
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
-587
Closed -$65K
ZUO
2803
DELISTED
Zuora, Inc.
ZUO
-328
Closed -$5K
USAP
2804
DELISTED
Universal Stainless & Alloy
USAP
-506
Closed -$8K
AY
2805
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
-92
Closed -$2K
LUMO
2806
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
-10
Closed
RCM
2807
DELISTED
R1 RCM Inc. Common Stock
RCM
-10,119
Closed -$127K
PETQ
2808
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
-636
Closed -$21K
CHUY
2809
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
-4,720
Closed -$108K
EGRX
2810
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-1,882
Closed -$105K
GTHX
2811
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
-599
Closed -$18K
EGIO
2812
DELISTED
Edgio, Inc. Common Stock
EGIO
-55
Closed -$6K
LSXMB
2813
DELISTED
Liberty Media Corporation Series B Liberty SiriusXM Common Stock
LSXMB
-12
Closed
ASXC
2814
DELISTED
Asensus Surgical, Inc.
ASXC
-25
Closed
AIU
2815
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
-19
Closed -$19K
LL
2816
DELISTED
LL Flooring Holdings, Inc.
LL
-10,683
Closed -$123K
TWOU
2817
DELISTED
2U Inc
TWOU
-301
Closed -$339K
MOR
2818
DELISTED
MorphoSys AG American Depositary Shares
MOR
-3,791
Closed -$92K
SBOW
2819
DELISTED
SilverBow Resources, Inc.
SBOW
-1
Closed
AINC
2820
DELISTED
Ashford Inc.
AINC
-3
Closed
HOLI
2821
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
-286
Closed -$5K
ETRN
2822
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
-27,661
Closed -$546K
OSG
2823
DELISTED
Overseas Shipholding Group Inc.
OSG
-325
Closed -$1K
CVLY
2824
DELISTED
Codorus Valley Bancorp Inc
CVLY
-551
Closed -$12K
MODN
2825
DELISTED
MODEL N, INC.
MODN
-2,424
Closed -$47K

Similar funds

Aperio Group's Q3 2019 Portfolio in Review

As of Q3 2019, Aperio Group held 3,081 positions worth $25.3B, up 3.3% from $24.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Aperio Group's Q3 2019 filing shows 5 new, 1,358 increased, 932 reduced and 769 closed positions. Its largest new stake was Genmab: 211,272 shares worth $4.28M. The largest sale was Pfizer, an estimated $34M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q3 2019 buy was Genmab: 211,272 shares worth $4.28M.
  • Aperio Group added most to Microsoft in Q3 2019, an estimated $31.9M increase.
  • Aperio Group's biggest Q3 2019 reduction was Pfizer, cutting an estimated $34M.
  • Aperio Group fully exited Red Hat Inc in Q3 2019, selling an estimated $22.2M.
  • Aperio Group's ten largest holdings make up 16% of its $25.3B portfolio in Q3 2019.
  • Aperio Group opened 5 new positions and closed 769 in Q3 2019.
  • Aperio Group's portfolio value rose 3.3% quarter-over-quarter to $25.3B.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.